OcuFLOW, INC is a premarket medical device company whose main product, after FDA-510K clearance,  is a technically superior composite pulsatile ocular blood flow analyzer (OcuFLOW-COBFA) that provides a solution to managing ocular blood flow and possibly delaying the progression of the three most common blinding ocular conditions including aging macular degeneration (AMD), diabetic retinopathy (DR) and glaucoma.